Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Chronic inflammation is crucial for the pathological process of tumors due to increasing the infiltration of cytokines, growth factors, and chemokines to the tumor microenvironment. Phenolic compounds are considered natural remedies for inflammation and cancer. Mangiferin is a C-glycosyl xanthone that , possesses numerous pharmacological activities. It has the potential to attenuate inflammation in different organs through the mechanisms of inhibiting pattern recognition receptors, regulating cell signaling pathways, activating autophagy, inhibiting the secretion of inflammatory mediators, and protecting intestinal barrier integrity, which in turn prevents cancer. In this review, the recent advances in the anti-inflammation and anti-cancer mechanisms of mangiferin as well as its safety and toxicity were summarized. The impacts of modified mangiferin and the synergic effects with other components were also discussed. Understanding the molecular targets of mangiferin is of great significance for its better application in the amelioration of inflammation-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
SHI, W., DENG, J., TONG, R., YANG, Y., HE, X., LV, J., WANG, H., DENG, S., QI, P., ZHANG, D., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4947 · Cited by 50
RetractedRor2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Mechanisms Regulating Intestinal Barrier Integrity and Its Pathological Implications
Chelakkot, C., Ghim, J., & Ryu, S. H. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0126-x · Cited by 2,017
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
The intestinal epithelium: central coordinator of mucosal immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S.-Y., Ko, H.-J., & Vallance, B. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.002 · Cited by 933
Breast Cancer and Its Relationship with the Microbiota
Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J., & Fontana, L. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081747 · Cited by 350
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Bayraktar, R., & Van Roosbroeck, K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9724-7 · Cited by 216
Mangiferin: A xanthonoid with multipotent anti‐inflammatory potential
Saha, S., Sadhukhan, P., & Sil, P. C. (2016) · BioFactors · doi:10.1002/biof.1292 · Cited by 166
Cited by
Mangiferin: A comprehensive review on its extraction, purification and uses in food systems
Castro-Muñoz, R., Cabezas, R., & Plata-Gryl, M. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103188 · Cited by 165
Mangiferin: a review of dietary sources, absorption, metabolism, bioavailability, and safety
Mei, S., Perumal, M., Battino, M., Kitts, D. D., Xiao, J., Ma, H., & Chen, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1983767 · Cited by 93
“We summarized the toxicity and safety of mangiferin in our previous review (Mei, Ma, and Chen 2021), here we updated some safety information about mangiferin and its nanoparticles.”
BackgroundSelf-citationRecent Formulation Advances of Mangiferin
Barakat, S., Nasr, M., Ahmed, R. F., Badawy, S., & Mortada, N. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00297-z · Cited by 28
“The first step in mangiferin’s metabolism is deglycosylation to the aglycone; norathyriol, with apparent bioavailability of 30.4% that is much higher than that of mangiferin (Mei et al. 2021a).”
BackgroundInfluentialFu, T.-L., Li, G.-R., Li, D.-H., He, R.-Y., Liu, B.-H., Xiong, R., Xu, C.-Z., Lu, Z.-L., Song, C.-K., Qiu, H.-L., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01202-7 · Cited by 27
From Nature to Nanotechnology: The Bioactivities of Mangiferin Explored
Al-Madhagi, H. (2025) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s525423 · Cited by 26
“39 Moreover, mangiferin neutralize and scavenge the produced reactive oxygen species (ROS) and reactive nitrogen species (RNS) in different organs such as the myocardium, renal tissues, liver, and lungs.”
Abdul-Aziz Ahmed, K., Jabbar, A. A. J., Abdulla, M. A., Zuhair Alamri, Z., Ain Salehen, N., Abdel Aziz Ibrahim, I., Almaimani, G., Bamagous, G. A., Almaimani, R. A., Almasmoum, H. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50947-y · Cited by 26
Sarfraz, M., Khan, A., Batiha, G. E.-S., Akhtar, M. F., Saleem, A., Ajiboye, B. O., Kamal, M., Ali, A., Alotaibi, N. M., Aaghaz, S., et al. (2023) · Cancers · doi:10.3390/cancers15164194 · Cited by 20
“, MGF inhibited the growth of hepatocellular carcinoma by controlling the suppression of the WT1-associated lymphoid enhancer-binding f ctor 1 (LEF1) by Wnt signaling [72], additionally, by enhancing the DNA damage after radiation and reducing the proliferation.”
BackgroundInfluentialZhou, H., Song, S., Lan, X., Li, Y., Yuan, X., Yang, J., Li, M., Cao, T., & Zhang, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c07089 · Cited by 15
Mangiferin: Sources, Anti-Inflammatory Activities, and Molecular Mechanisms
Shang, Y., Tian, J., Zhang, Z., Luo, L., Saeheng, S., Qiu, S., Zhou, R., Chen, J., & Li, L. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c06234 · Cited by 12
Vishwakarma, K. K., Hafeez, A., Usmani, S. A., Noor, L., & Khan, I. R. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318524240907135527 · Cited by 4
Mangiferin in human disease: Multifaceted mechanisms and applications (Review)
Dai, Y., Huang, Q., Tan, M., Wang, Z., Jiang, C., Liu, Z., Zhang, S., & Song, S. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5736 · Cited by 7
“…signaling axis, distinguishing between redox‑regulated Nrf2 signaling, inflammatory NF‑ κ B activa‑ tion and metabolic AMPK modulation, as summarized in reviews of the molecular mechanisms of MGF in cancer/inflam‑ mation and liver disease, including the NF‑ κ B, Nrf2 and AMPK pathways (198,199).”
A review on formulation and analytical aspect of mangiferin a natural phenolic xanthonoid
Shaikh, I., & Tatapudi, H. K. (2025) · Discover Chemistry · doi:10.1007/s44371-025-00193-0 · Cited by 3
Metadata
- Authors
- Mei, S., Ma, H., & Chen, X.
- Venue
- Food and Chemical Toxicology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 149
- Pages
- 111997
- ISSN
- 0278-6915 (ISSN-L)
- OpenAlex
- W3125064248
- Cited by
- 98
- References
- 37
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.